Lupin Looks “Down Under” For Generic Growth As Deal Spree Continues
This article was originally published in The Pink Sheet Daily
Indian firm buys stake in Australian generics, OTC firm Generic Health.
You may also be interested in...
World's Largest TB Drug Maker Lupin Acquires German Generic Company Hormosan To Extend Reach Into Europe
MUMBAI - Lupin, the world's largest manufacturer of anti-TB drugs, has acquired German generics firm Hormosan Pharma GmbH to establish a "bridgehead" and sharpen its focus in the European market
Deal marks first major step for Indian pharma into Japan.
A rising number of enforcement actions by major drug regulators like the U.S. FDA is slowly making investors cautious about the longer term repercussions on earnings of Indian drug makers.